Biotech Has a Rare, $516 Million Moment of Brightness

March 25, 2013 at 2:59 pm PT

The announcement by Third Rock Ventures today that it has raised $516 million to create about 15 new biotechnology companies over the next few years marks a bright moment amid the tough climate for life sciences startups.

The bottom fell out for young biotechs after the economic downturn. Last year offered no relief, with venture investments in life sciences falling 14 percent from the year earlier to $6.6 billion, according to a MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association based on data from Thomson Reuters.

Read the rest of this post on the original site »

Tagged with: biotech, biotechnology, start-ups, Third Rock Ventures, venture capital

Must-Reads from other Websites

Why Apple Should Buy China’s Xiaomi

Panos Mourdoukoutas, Contributor, Forbes

What I Didn’t Say

Paul Graham, Founder, ViaWeb

We Need to Talk About TED

Benjamin Bratton, Journalist, The Guardian

I, Glasshole: My Year With Google Glass

Mat Honan, Senior Writer, Wired

All Together Now

Chris Ware, Writer, The New Yorker

The Sculpture on the Moon

Corey S. Powell and Laurie Gwen Shapiro, Contributors, Slate

About Voices

Along with original content and posts from across the Dow Jones network, this section of AllThingsD includes Must-Reads From Other Websites — pieces we’ve read, discussions we’ve followed, stuff we like. Six posts from external sites are included here each weekday, but we only run the headlines. We link to the original sites for the rest. These posts are explicitly labeled, so it’s clear that the content comes from other websites, and for clarity’s sake, all outside posts run against a pink background.

We also solicit original full-length posts and accept some unsolicited submissions.